BIOTECH TARGET N V

Average Profitability
<0.0001%
Insider Buys Quantity
83
Insider Buys Sum
$170.76M
Insider Sells Quantity
1
Insider Sells Sum
$845,833.04

Insider Activity of BIOTECH TARGET N V

According to the SEC Form 4 filings, BIOTECH TARGET N V, being in a position of

  1. 10 percent owner at Molecular Templates, Inc.,
    оver the last 12 months, has bought 250000 shares for $587,500, and sold 1279820 shares for $845,833,
    over all time since 2020-10-28, has bought 10427326 shares for $56.02M, and sold 1279820 shares for $845,833.

The largest purchase of all time was on 2021-02-18 and amounted to 1185770 shares of Molecular Templates, Inc. for $15M.

The largest sale of all time was on 2024-11-14 and amounted to 1279820 shares of Molecular Templates, Inc. for $845,833.

Biography of BIOTECH TARGET N V

No biography is available at this moment.

2024-11-14SaleMolecular Templates, Inc.
MTEM
10 percent owner
1.28M
20.6511%
$0.66$845,8330%
2024-04-02PurchaseMolecular Templates, Inc.
MTEM
10 percent owner
250,000
5.7535%
$2.35$587,500-28.16%
2023-10-02PurchaseMacroGenics, Inc.
MGNX
10 percent owner
150,000
0.2413%
$4.46$669,585+69.31%
2023-09-07PurchaseMacroGenics, Inc.
MGNX
10 percent owner
200,000
0.324%
$5.26$1.05M+42.05%
2023-07-17PurchaseMolecular Templates, Inc.
MTEM
10 percent owner
4.26M
6.4706%
$0.47$2M-53.81%
2023-02-14PurchaseMacroGenics, Inc.
MGNX
10 percent owner
500,000
0.7819%
$5.07$2.53M+15.84%
2023-01-19PurchaseMacroGenics, Inc.
MGNX
director
150,000
0.245%
$5.30$794,925+10.19%
2022-12-27PurchaseMacroGenics, Inc.
MGNX
director
200,000
0.3249%
$5.61$1.12M+1.33%
2022-12-23PurchaseMacroGenics, Inc.
MGNX
director
200,000
0.3225%
$5.88$1.18M-4.21%
2022-11-22PurchaseMacroGenics, Inc.
MGNX
director
300,000
0.471%
$5.96$1.79M-7.93%
2022-10-24PurchaseMacroGenics, Inc.
MGNX
director
250,000
0.4034%
$4.36$1.09M+29.43%
2022-10-21PurchaseMacroGenics, Inc.
MGNX
director
250,000
0.3924%
$4.63$1.16M+18.75%
2022-10-20PurchaseMacroGenics, Inc.
MGNX
director
285,977
0.4631%
$4.00$1.14M+41.67%
2022-10-19PurchaseMacroGenics, Inc.
MGNX
director
168,422
0.2659%
$3.70$623,919+49.48%
2022-05-18PurchaseRadius Health, Inc.
RDUS
10 percent owner
477,824
0.4823%
$5.57$2.66M-11.81%
2022-01-06PurchaseMolecular Templates, Inc.
MTEM
10 percent owner
200,000
0.3471%
$4.04$807,180-77.97%
2022-01-06PurchaseRadius Health, Inc.
RDUS
10 percent owner
300,000
0.3433%
$6.31$1.89M-22.3%
2022-01-05PurchaseRadius Health, Inc.
RDUS
10 percent owner
250,000
0.2854%
$6.30$1.57M-32.62%
2021-11-19PurchaseMacroGenics, Inc.
MGNX
10 percent owner
200,000
0.3261%
$18.50$3.7M-72.08%
2021-09-29PurchaseMacroGenics, Inc.
MGNX
10 percent owner
100,000
0.1634%
$20.47$2.05M-57.83%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.